Cisplatin

CHEMBL11359 Phase 4 승인됨 Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
300.0 g/mol
LogP
Phase
4

A platinum-based chemotherapy agent that forms crosslinks between DNA strands, disrupting DNA replication and transcription, leading to cancer cell death. It is a cornerstone of treatment for testicular, ovarian, bladder, lung, and head and neck cancers. Nephrotoxicity, ototoxicity, nausea, and peripheral neuropathy are major dose-limiting toxicities requiring vigorous supportive care.

분자량

300.0500 g/mol

TPSA

2.00 Ų

치료 영역

Pharmacokinetics (PK)

Pharmacodynamics (PD)

2D 구조

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

N.N.Cl[Pt]Cl

InChI

InChI=1S/2ClH.2H3N.Pt/h2*1H;2*1H3;/q;;;;+2/p-2

Molecular Formula

Cl2H6N2Pt

HBD / HBA

2 / 2

회전 가능 결합

0

무거운 원자

5

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

자주 묻는 질문

A platinum-based chemotherapy agent that forms crosslinks between DNA strands, disrupting DNA replication and transcription, leading to cancer cell death. It is a cornerstone of treatment for testicular, ovarian, bladder, lung, and head and neck cancers. Nephrotoxicity, ototoxicity, nausea, and peripheral neuropathy are major dose-limiting toxicities requiring vigorous supportive care.

Yes, Cisplatin is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL11359. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 5460033. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

의학적 면책조항

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.